Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Total 13F shares
-
2,804,345
-
Share change
-
-979,629
-
Total reported value
-
$11,247,922
-
Put/Call ratio
-
216%
-
Price per share
-
$4.01
-
Number of holders
-
31
-
Value change
-
-$4,241,878
-
Number of buys
-
17
-
Number of sells
-
21
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q3 2021
As of 30 Sep 2021,
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,804,345 shares.
The largest 10 holders included
VANGUARD GROUP INC, Ikarian Capital, LLC, JACOB ASSET MANAGEMENT OF NEW YORK LLC, Manatuck Hill Partners, LLC, COOPERMAN LEON G, GEODE CAPITAL MANAGEMENT, LLC, Stonepine Capital Management, LLC, NORTHERN TRUST CORP, TWO SIGMA ADVISERS, LP, and TWO SIGMA INVESTMENTS, LP.
This page lists
31
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.